Ensysce Biosciences Inc (ENSC)
0.5805
-0.05
(-7.83%)
USD |
NASDAQ |
Apr 18, 16:00
0.5805
0.00 (0.00%)
After-Hours: 20:00
Ensysce Biosciences Shareholders Equity (Quarterly): -0.3229M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3229M |
| September 30, 2023 | 1.485M |
| June 30, 2023 | 4.119M |
| March 31, 2023 | 0.1667M |
| December 31, 2022 | -3.714M |
| September 30, 2022 | -6.094M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.4916M |
| March 31, 2022 | 1.391M |
| December 31, 2021 | -7.878M |
| September 30, 2021 | -0.1057M |
| June 30, 2021 | 5.411M |
| December 31, 2020 | -6.441M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.878M
Minimum
Dec 2021
5.411M
Maximum
Jun 2021
-1.040M
Average
-0.2143M
Median
Shareholders Equity (Quarterly) Benchmarks
| Processa Pharmaceuticals Inc | 4.989M |
| Omeros Corp | -24.98M |
| Relmada Therapeutics Inc | 85.36M |
| Myomo Inc | 8.989M |
| MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.708M |
| Total Liabilities (Quarterly) | 3.359M |